Sarepta Therapeutics
SRPT
#1636
Rank
โ‚น903.55 B
Marketcap
โ‚น9,325
Share price
3.58%
Change (1 day)
-9.14%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น207.79 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are โ‚น207.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น200.23 B-11.8%
2022-12-31โ‚น227.01 B37.39%
2021-12-31โ‚น165.23 B1.64%
2020-12-31โ‚น162.57 B126.93%
2019-12-31โ‚น71.64 B68.02%
2018-12-31โ‚น42.63 B28.73%
2017-12-31โ‚น33.12 B457.6%
2016-12-31โ‚น5.94 B7.13%
2015-12-31โ‚น5.54 B84.65%
2014-12-31โ‚น3.00 B9.53%
2013-12-31โ‚น2.74 B-38.42%
2012-12-31โ‚น4.45 B260.42%
2011-12-31โ‚น1.23 B-43.5%
2010-12-31โ‚น2.18 B29.46%
2009-12-31โ‚น1.68 B258.39%
2008-12-31โ‚น0.47 B-2.03%
2007-12-31โ‚น0.48 B244.67%
2006-12-31โ‚น0.13 B12.85%
2005-12-31โ‚น0.12 B26.93%
2004-12-31โ‚น97.42 M-42.95%
2003-12-31โ‚น0.17 B-30.47%
2002-12-31โ‚น0.24 B55.15%
2001-12-31โ‚น0.15 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น3.156 T 1,419.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น195.56 B-5.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.00 B-94.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น83.84 B-59.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น364.50 B 75.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น253.01 B 21.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น151.97 B-26.86%๐Ÿ‡บ๐Ÿ‡ธ USA